Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus
- PMID: 8759744
Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus
Abstract
The immunogenic properties of a replication-defective herpes simplex virus HD-2, containing the Escherichia coli lacZ gene under control of the HSV ICP8 early gene promoter were studied in BALB/c mice. Experiments were designed to determine if the HD-2 virus preferentially stimulated either Th1- or Th2-associated immune responses to beta-galactosidase (beta gal). Sera from mice immunized i.p. or s.c. with virus HD-2, beta gal on aluminum phosphate adjuvant, or a control ICP8 deletion mutant, d301, were assayed for total and Ag-specific IgG1 and IgG2a Abs, beta gal-driven lymphocyte proliferation, and in vitro production of the cytokines IFN-gamma, IL-4, and IL-2. Viruses HD-2 and d301 preferentially stimulated the production of total serum IgG2a following two immunizations i.p. or a single immunization s.c., while only HD-2 virus stimulated in vivo production of beta gal-specific IgG2a serum Abs. In contrast, beta gal adsorbed on AIPO4 preferentially stimulated production of Ag-specific IgG1 serum Abs. The HD-2 virus also induced a potent cellular proliferative response to beta gal, which was still pronounced 5 wk after primary immunization. Cultured lymphocytes from HD-2-immunized mice produced IFN-gamma after 5 days in culture with soluble beta gal in an Ag- and dose-dependent fashion. These results demonstrate that replication-defective mutants of HSV can be used as vectors for eliciting Th1-associated immune responses to a heterologous Ag expressed from the viral genome.
Similar articles
-
Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.Gene Ther. 1999 Apr;6(4):629-36. doi: 10.1038/sj.gt.3300859. Gene Ther. 1999. PMID: 10476222
-
Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.Virology. 2007 Jan 20;357(2):186-98. doi: 10.1016/j.virol.2006.08.015. Epub 2006 Sep 22. Virology. 2007. PMID: 16996101
-
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.Eur J Immunol. 1995 Dec;25(12):3467-73. doi: 10.1002/eji.1830251239. Eur J Immunol. 1995. PMID: 8566039
-
Minireview: the herpes simplex virus amplicon--a versatile defective virus vector.Gene Ther. 1994;1 Suppl 1:S40-6. Gene Ther. 1994. PMID: 8542394 Review.
-
Replication-defective recombinant herpes simplex virus vectors.Methods Cell Biol. 1994;43 Pt A:211-30. doi: 10.1016/s0091-679x(08)60605-6. Methods Cell Biol. 1994. PMID: 7823863 Review. No abstract available.
Cited by
-
Humoral response to herpes simplex virus is complement-dependent.Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12708-12. doi: 10.1073/pnas.96.22.12708. Proc Natl Acad Sci U S A. 1999. PMID: 10535987 Free PMC article.
-
Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector.Virology. 2016 Sep;496:186-193. doi: 10.1016/j.virol.2016.06.006. Epub 2016 Jun 20. Virology. 2016. PMID: 27336950 Free PMC article.
-
Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.J Virol. 1999 Dec;73(12):10214-23. doi: 10.1128/JVI.73.12.10214-10223.1999. J Virol. 1999. PMID: 10559338 Free PMC article.
-
Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.J Virol. 2002 Apr;76(8):3678-87. doi: 10.1128/jvi.76.8.3678-3687.2002. J Virol. 2002. PMID: 11907207 Free PMC article.
-
Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.J Virol. 2000 Dec;74(23):11137-44. doi: 10.1128/jvi.74.23.11137-11144.2000. J Virol. 2000. PMID: 11070010 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources